v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating Activities        
Net loss $ (1,869,895) $ (399,897) $ (2,608,351) $ (1,241,708)
Adjustments to reconcile net loss to net cash used in (provided by) operating activities        
Depreciation 105 418
Share-based compensation     29,847 65,022
Expenses settled in stock     79,000
Acquired in-process research and development expense 1,500,000 1,500,000
Change in operating assets and liabilities:        
Prepaid expenses     56,623 80,981
Accounts payable     (63,790) 118,576
Related party payable     205,835 39,244
Accrued expenses     15,652 (14,279)
Net cash used in (provided by) operating activities     (864,184) (872,746)
Financing Activities        
Advances from related party     935,000 957,000
Payments on note payable     (69,442) (74,909)
Net cash used in (provided by) financing activities     865,558 882,091
(Decrease)/Increase in cash     1,374 9,345
Cash, beginning of period     13,929 5,046
Cash, end of period $ 15,303 $ 14,391 15,303 14,391
Supplemental disclosure of noncash investing and financing activities        
Issuance of Note Payable for payment of prepaid expense     87,409 92,597
Cash paid for interest     1,594 1,854
Shares issued pending non-cash transaction     $ 1,500,000